(Q33860719)

29 July 2017

1 reference

title

How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis (English)

1 reference

29 July 2017

0 references

Livingston G

1

1 reference

29 July 2017

Katona C

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

International Journal of Geriatric Psychiatry

29 July 2017

published in

1 reference

29 July 2017

volume

15

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

203-207

1 reference

Confidence intervals for the number needed to treat

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200003%2915%3A3%3C203%3A%3AAID-GPS100%3E3.0.CO%3B2-9

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200003%2915%3A3%3C203%3A%3AAID-GPS100%3E3.0.CO%3B2-9

Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200003%2915%3A3%3C203%3A%3AAID-GPS100%3E3.0.CO%3B2-9

Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200003%2915%3A3%3C203%3A%3AAID-GPS100%3E3.0.CO%3B2-9

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200003%2915%3A3%3C203%3A%3AAID-GPS100%3E3.0.CO%3B2-9

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200003%2915%3A3%3C203%3A%3AAID-GPS100%3E3.0.CO%3B2-9

10.1002/(SICI)1099-1166(200003)15:3<203::AID-GPS100>3.0.CO;2-9

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference